Larvol Delta - A-MULTICENTER-RANDOMIZED-DOUBLEBLIND-PLACEBOCONTROLLED-PARALLEL-GROUP-STUDY-TO-ASSESS-TOLERABILITY-SAFETY-PHARMACOKINETICS-AND-EFFECT-OF-AZP2006-ON-CEREBROSPINAL-FLUID-BIOMARKERS-IN-36-PATIENTS-WITH-PROGRESSIVE-SUPRANUCLEAR-PALSY

ezeprogind (AZP2006) - AlzProtect

https://www.ctad-alzheimer.com/files/files/JPAD%20CTAD%20abstracts.pdf

P. Verwaerde1; N. Callizot1; S. Del Signore1; A. Blondel1; C. Estrella1

Dec 9, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next